ZNF793 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.036100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.614200E-01
Normal-vs-Stage2
2.897400E-03
Normal-vs-Stage3
1.549040E-01
Normal-vs-Stage4
2.171800E-01
Stage1-vs-Stage2
1.761030E-01
Stage1-vs-Stage3
6.513800E-02
Stage1-vs-Stage4
4.062600E-01
Stage2-vs-Stage3
5.997900E-03
Stage2-vs-Stage4
5.463000E-01
Stage3-vs-Stage4
1.600760E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.575830E-02
Normal-vs-AfricanAmerican
1.797570E-01
Normal-vs-Asian
3.499600E-02
Caucasian-vs-AfricanAmerican
3.550400E-02
Caucasian-vs-Asian
6.950600E-01
AfricanAmerican-vs-Asian
3.688000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.984000E-03
Normal-vs-Female
2.727700E-02
Male-vs-Female
2.436200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.552200E-01
Normal-vs-Age(41-60Yrs)
1.314310E-02
Normal-vs-Age(61-80Yrs)
7.799200E-03
Normal-vs-Age(81-100Yrs)
2.430400E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.436200E-04
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.85369999999541E-05
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.139560E-03
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.666800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.721200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.711400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.343200E-03
Normal-vs-Daily Drinker
7.556800E-03
Normal-vs-Weekly Drinker
2.095000E-01
Normal-vs-Occasional Drinker
1.418210E-01
Normal-vs-Social Drinker
9.795900E-02
Non Drinker-vs-Daily Drinker
7.615800E-01
Non Drinker-vs-Weekly Drinker
6.940000E-01
Non Drinker-vs-Occasional Drinker
3.374400E-01
Non Drinker-vs-Social Drinker
3.459000E-01
Daily Drinker-vs-Weekly Drinker
9.670600E-01
Daily Drinker-vs-Occasional Drinker
2.677200E-01
Daily Drinker-vs-Social Drinker
2.584400E-01
Weekly Drinker-vs-Occasional Drinker
2.552400E-01
Weekly Drinker-vs-Social Drinker
2.473800E-01
Occasional Drinker-vs-Social Drinker
9.656200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.422800E-01
Normal-vs-Grade 2
3.502400E-01
Normal-vs-Grade 3
3.425600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.167400E-01
Grade 1-vs-Grade 3
2.347600E-01
Grade 1-vs-Grade 4
3.422800E-01
Grade 2-vs-Grade 3
9.834600E-01
Grade 2-vs-Grade 4
3.502400E-01
Grade 3-vs-Grade 4
3.425600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.034490E-02
Normal-vs-NonDiabetic
1.072450E-02
Diabetic-vs-NonDiabetic
8.257600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.603410E-01
Normal-vs-NoPancreatitis
6.856200E-03
Pancreatitis-vs-NoPancreatitis
1.015440E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.979510E-02
Normal-vs-N1
4.683300E-03
N0-vs-N1
5.557400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.594400E-01
Normal-vs-TP53-NonMutant
1.245630E-01
TP53-Mutant-vs-TP53-NonMutant
4.873600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
